SCHEMBL8343305

SCHEMBL8343305

N#CC1C=Cc2ccccc2N1C(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.68
▸ MEN1 O00255 3/20 0.68
▸ KMT2A Q03164 3/20 0.68
▸ ALDH1A1 P00352 2/20 0.68
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ TSHR P16473 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ P2RX4 Q99571 2/20 0.40
▸ ELANE P08246 1/20 0.39
▸ DPP4 P27487 1/20 0.39
▸ ATM Q13315 1/20 0.38
▸ HPGD P15428 1/20 0.37
▸ HSD11B1 P28845 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ ELOVL6 Q9H5J4 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8342323 0.86 LMNA (0.72) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8342494 0.86 LMNA (0.75) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL9369302 0.85 LMNA (0.78) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL29624123 0.84 KMT2A (0.72) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL9365789 0.84 KMT2A (0.72) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL9365729 0.84 LMNA (0.72) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL9365388 0.84 LMNA (0.72) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8342786 0.83 LMNA (0.68) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL9365671 0.81 LMNA (0.46) LMNAMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL9365677 0.81 LMNA (0.46) LMNAMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992016508-A1 REISSERT COMPOUNDS AS ANTI-HIV AGENTS THE UPJOHN COMPANY (US) 1992-10-01 — — WO claimed
US-5939435-A TREATMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE AMERICAN HOME PRODUCTS CORPORATION (US) 1999-08-17 — — US disclosed
WO-1998033775-A1 2-SUBSTITUTED-1-ACYL-1,2-DIHYDROQUINOLINE DERIVATIVES TO INCREASE HDL-CHOLESTEROL LEVEL AMERICAN HOME PRODUCTS CORPORATION (US) 1998-08-06 — — WO disclosed
EP-0579695-A1 REISSERT COMPOUNDS AS ANTI-HIV AGENTS THE UPJOHN COMPANY (US) 1994-01-26 — — EP disclosed
WO-1992016508-A1 REISSERT COMPOUNDS AS ANTI-HIV AGENTS THE UPJOHN COMPANY (US) 1992-10-01 — — WO disclosed
Send feedback